Literature DB >> 9822761

Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus.

A M Mazarati1, H Liu, U Soomets, R Sankar, D Shin, H Katsumori, U Langel, C G Wasterlain.   

Abstract

We examined the role of hippocampal galanin in an animal model of status epilepticus (SE). Control rats showed abundant galanin-immunoreactive (Gal-IR) fibers in the dentate hilus, whereas no Gal-IR neurons were observed. Three hours after the onset of self-sustaining SE (SSSE), induced either by intermittent stimulation of the perforant path for 30 min (PPS) or by injection of lithium and pilocarpine, Gal-IR fibers disappeared in the hilus and remained absent for up to 1 week afterward. Twelve hours after the induction of SE by PPS or 3 hr after pilocarpine administration, Gal-IR neurons appeared in the hilus; these neurons increased in number after 1 d and gradually declined 3 and 7 d later. Galanin concentration in the hippocampus, measured by ELISA, significantly decreased on the plateau of SSSE and increased 24 hr after PPS. Galanin (0.05 nmol) injected into the hilus prevented the induction of SSSE, and 0.5 nmol of galanin stopped established SSSE. These effects were attenuated by galanin receptor antagonists (M35 > M40 >/= M15). 2-Ala-galanin (5 nmol), a putative agonist of galanin type 2 receptors, prevented but was unable to stop SSSE. M35 facilitated the development of SSSE when given before PPS. We suggest that hippocampal galanin acts as an endogenous anticonvulsant via galanin receptors. SE-induced galanin depletion in the hippocampus may contribute to the maintenance of seizure activity, whereas the increase of galanin concentration and the appearance of galanin-immunoreactive neurons may favor the cessation of SSSE. The seizure-protecting action of galanin SSSE opens new perspectives in the treatment of SE.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822761      PMCID: PMC6793305     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  60 in total

Review 1.  Galanin and galanin antagonists: molecular and biochemical perspectives.

Authors:  T Bartfai; G Fisone; U Langel
Journal:  Trends Pharmacol Sci       Date:  1992-08       Impact factor: 14.819

2.  Identification and molecular characterization of galanin receptor sites in rat brain.

Authors:  A L Servin; B Amiranoff; C Rouyer-Fessard; K Tatemoto; M Laburthe
Journal:  Biochem Biophys Res Commun       Date:  1987-04-14       Impact factor: 3.575

3.  Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover.

Authors:  K E Smith; C Forray; M W Walker; K A Jones; J A Tamm; J Bard; T A Branchek; D L Linemeyer; C Gerald
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

4.  Galanin receptor and its ligands in the rat hippocampus.

Authors:  G Fisone; U Langel; M Carlquist; T Bergman; S Consolo; T Hökfelt; A Undén; S Andell; T Bartfai
Journal:  Eur J Biochem       Date:  1989-04-15

Review 5.  Identification and preclinical testing of novel antiepileptic compounds.

Authors:  B S Meldrum
Journal:  Epilepsia       Date:  1997       Impact factor: 5.864

6.  Galanin antagonizes acetylcholine on a memory task in basal forebrain-lesioned rats.

Authors:  J Mastropaolo; N S Nadi; N L Ostrowski; J N Crawley
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Focal cortical seizures prevent HRP and HRP-WGA labeling only in neurons bidirectionally connected to the cortex.

Authors:  I Divac; B Petrovic-Minic; J Mogensen
Journal:  Brain Res       Date:  1984-10-08       Impact factor: 3.252

Review 8.  Galanin--a neuropeptide with inhibitory actions.

Authors:  K Kask; U Langel; T Bartfai
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

9.  Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures.

Authors:  A Vezzani; C Schwarzer; E W Lothman; J Williamson; G Sperk
Journal:  Epilepsy Res       Date:  1996-12       Impact factor: 3.045

10.  Serum neuron-specific enolase is a marker for neuronal damage following status epilepticus in the rat.

Authors:  R Sankar; D H Shin; C G Wasterlain
Journal:  Epilepsy Res       Date:  1997-09       Impact factor: 3.045

View more
  38 in total

1.  Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease.

Authors:  R A Steiner; J G Hohmann; A Holmes; C C Wrenn; G Cadd; A Juréus; D K Clifton; M Luo; M Gutshall; S Y Ma; E J Mufson; J N Crawley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

2.  Nociceptin reduces epileptiform events in CA3 hippocampus via presynaptic and postsynaptic mechanisms.

Authors:  M K Tallent; S G Madamba; G R Siggins
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

3.  Modulation of hippocampal excitability and seizures by galanin.

Authors:  A M Mazarati; J G Hohmann; A Bacon; H Liu; R Sankar; R A Steiner; D Wynick; C G Wasterlain
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

4.  Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests.

Authors:  Tamas Bartfai; Xiaoying Lu; Hedieh Badie-Mahdavi; Alasdair M Barr; Andrey Mazarati; Xiao-Ying Hua; Tony Yaksh; Gebhard Haberhauer; Susana Conde Ceide; Laurent Trembleau; Laszlo Somogyi; Lenz Kröck; Julius Rebek
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

Review 5.  Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment.

Authors:  Jerome Niquet; Roger Baldwin; Lucie Suchomelova; Lucille Lumley; David Naylor; Roland Eavey; Claude G Wasterlain
Journal:  Ann N Y Acad Sci       Date:  2016-07-08       Impact factor: 5.691

6.  Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli.

Authors:  P Szot; D Weinshenker; S S White; C A Robbins; N C Rust; P A Schwartzkroin; R D Palmiter
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

Review 7.  Current prospects and challenges for epilepsy gene therapy.

Authors:  Marc S Weinberg; Thomas J McCown
Journal:  Exp Neurol       Date:  2011-10-08       Impact factor: 5.330

8.  A promising genetic approach for the treatment of epilepsy.

Authors:  Robyn Wallace
Journal:  Epilepsy Curr       Date:  2004 Jul-Aug       Impact factor: 7.500

9.  Galanin receptors modulate seizures.

Authors:  Jaideep Kapur
Journal:  Epilepsy Curr       Date:  2011-07       Impact factor: 7.500

Review 10.  Neuronal plasticity in animal models and the epileptic human hippocampus.

Authors:  Gunther Sperk; Meinrad Drexel; Susanne Pirker
Journal:  Epilepsia       Date:  2009-12       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.